184 related articles for article (PubMed ID: 23113605)
1. Clinical impact of inappropriate initial antimicrobial therapy on outcome in bacteremic biliary tract infections.
Kang CI; Sung YK; Lee KH; Lee KT; Lee JK
Scand J Infect Dis; 2013 Mar; 45(3):227-34. PubMed ID: 23113605
[TBL] [Abstract][Full Text] [Related]
2. Impact of inappropriate empirical antibiotic therapy on outcome of bacteremic adults visiting the ED.
Lee CC; Lee CH; Chuang MC; Hong MY; Hsu HC; Ko WC
Am J Emerg Med; 2012 Oct; 30(8):1447-56. PubMed ID: 22205015
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and outcome of Pseudomonas aeruginosa bacteremia among adults visiting the ED.
Lee CC; Lee CH; Hong MY
Am J Emerg Med; 2012 Jul; 30(6):852-60. PubMed ID: 21855263
[TBL] [Abstract][Full Text] [Related]
4. Different impact of the appropriateness of empirical antibiotics for bacteremia among younger adults and the elderly in the ED.
Lee CC; Chang CM; Hong MY; Hsu HC; Ko WC
Am J Emerg Med; 2013 Feb; 31(2):282-90. PubMed ID: 23000336
[TBL] [Abstract][Full Text] [Related]
5. The clinical epidemiology and outcomes of bacteremic biliary tract infections caused by antimicrobial-resistant pathogens.
Sung YK; Lee JK; Lee KH; Lee KT; Kang CI
Am J Gastroenterol; 2012 Mar; 107(3):473-83. PubMed ID: 22334249
[TBL] [Abstract][Full Text] [Related]
6. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
7. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Antimicrob Agents Chemother; 2005 Feb; 49(2):760-6. PubMed ID: 15673761
[TBL] [Abstract][Full Text] [Related]
8. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for mortality and impact of broad-spectrum cephalosporin resistance on outcome in bacteraemic intra-abdominal infections caused by Gram-negative bacilli.
Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
Scand J Infect Dis; 2011 Mar; 43(3):202-8. PubMed ID: 21142623
[TBL] [Abstract][Full Text] [Related]
10. [Bacteremic colangitis in adults in a general hospital in Chile].
Fica A; Julio V; Palma E; Guinez D; Porte L; Braun S; Dabanch J
Rev Chilena Infectol; 2013 Feb; 30(1):65-73. PubMed ID: 23450413
[TBL] [Abstract][Full Text] [Related]
11. Impact of inappropriate empiric antimicrobial therapy on outcome in Pseudomonas aeruginosa bacteraemia: a stratified analysis according to sites of infection.
Joo EJ; Kang CI; Ha YE; Park SY; Kang SJ; Wi YM; Lee NY; Chung DR; Peck KR; Song JH
Infection; 2011 Aug; 39(4):309-18. PubMed ID: 21594653
[TBL] [Abstract][Full Text] [Related]
12. Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Wang SS; Lee NY; Hsueh PR; Huang WH; Tsui KC; Lee HC; Wu CJ; Chang CM; Huang CC; Huang CF; Ko WC
J Microbiol Immunol Infect; 2011 Aug; 44(4):282-8. PubMed ID: 21524962
[TBL] [Abstract][Full Text] [Related]
13. Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis.
Lee SS; Kim Y; Chung DR
J Infect; 2011 Feb; 62(2):159-64. PubMed ID: 21055417
[TBL] [Abstract][Full Text] [Related]
14. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection.
Lee YT; Kuo SC; Yang SP; Lin YT; Tseng FC; Chen TL; Fung CP
Clin Infect Dis; 2012 Jul; 55(2):209-15. PubMed ID: 22495546
[TBL] [Abstract][Full Text] [Related]
15. Biliary tract infections: a guide to drug treatment.
Westphal JF; Brogard JM
Drugs; 1999 Jan; 57(1):81-91. PubMed ID: 9951953
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and prognostic determinants of bacteraemic biliary tract infection.
Ortega M; Marco F; Soriano A; Almela M; Martínez JA; López J; Pitart C; Mensa J
J Antimicrob Chemother; 2012 Jun; 67(6):1508-13. PubMed ID: 22408140
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcomes in patients with third-generation cephalosporin-resistant Enterobacter bacteremia.
O'Neal CS; O'Neal HR; Daniels TL; Talbot TR
Scand J Infect Dis; 2012 Oct; 44(10):726-32. PubMed ID: 22681412
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of Gram-negative nonfermenters on adults with community-onset bacteremia in the emergency department.
Chiu CW; Li MC; Ko WC; Li CW; Chen PL; Chang CM; Lee NY; Lee CC
J Microbiol Immunol Infect; 2015 Feb; 48(1):92-100. PubMed ID: 24060496
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and impact of empirical therapy in cirrhotic adults with community-onset bacteremia.
Hsieh CC; Lee CC; Chan TY; Hong MY; Chi CH; Ko WC
Am J Emerg Med; 2015 Feb; 33(2):222-8. PubMed ID: 25498529
[TBL] [Abstract][Full Text] [Related]
20. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment.
Zarkotou O; Pournaras S; Tselioti P; Dragoumanos V; Pitiriga V; Ranellou K; Prekates A; Themeli-Digalaki K; Tsakris A
Clin Microbiol Infect; 2011 Dec; 17(12):1798-803. PubMed ID: 21595793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
